OBIZUR 500 U, powder and solvent for solution for injection bottle
Active ingredients: SUSOCTOCOG ALFA
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Powder and solvent for solution for injectionbottleintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- OBIZUR 500 U, poudre et solvant pour solution injectable
- Pharmaceutical form
- poudre et solvant pour solution injectable
- Route of administration
- intraveineuse
- Presentation description
- 1 flacon(s) en verre - 1 seringue(s) préremplie(s) en verre avec adaptateur(s) pour flacon avec dispositif(s) de transfert
- Marketing authorisation holder
- BAXALTA INNOVATIONS (AUTRICHE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 13 Feb 2019
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Hospital use only
- Enhanced ANSM monitoring
- Yes
BDPM identifiers
CIS
65982247CIP75501655CIP133400955016557Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| SUSOCTOCOG ALFApoudre | 500 U · un flacon | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.